Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis

Author： Braun Juergen   Baraliakos Xenofon   Heldmann Frank   Kiltz Uta  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.23, Iss.5, 2014-05, pp. : 647-659

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis

By Ranganathan Prabha  

Pharmacogenomics, Vol. 6, Iss. 5, 2005-07 ,pp. : 481-490

Future Medicine

Access to resources Recommend Favorite

Managing Crohn Disease in Children and Adolescents: Focus on Tumor Necrosis Factor Antagonists

By Saeed Shehzad A.  

Pediatric Drugs, Vol. 10, Iss. 1, 2008-01 ,pp. : 31-38

Adis International

Access to resources Recommend Favorite

Is There Any Future for Tumor Necrosis Factor Antagonists in Chronic Heart Failure?

By Arthur M. Feldman  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 1, 2004-01 ,pp. : 11-19

Adis International

Access to resources Recommend Favorite

Failing To Mend A Broken Heart But Still Hope for Tumor Necrosis Factor- Antagonists

By Arthur Feldman   Charles Mctiernan  

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 3, 2004-06 ,pp. : 8-12

Adis International

Access to resources Recommend Favorite

Tumour necrosis factor antagonists

By Chantry D.  

Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. : 5-13

Informa Healthcare

Access to resources Recommend Favorite